FINAL PART:
After an appropriate period of Oestragen therapy, the levels achieved are within the satisfactory female 400 to 600. However, in some cases there is a failure in testosterone suppression and its levels remail refractory, in the male range.
TREATMENT MODIFICATION:
Additional therapy is in the form of Decapeptyl 11.25 mgs every 12 weeks as an addition to current therapy, in order to suppress the testosterone production.
For the initial 2 weeks following injection No 1, the physician will co-administer Cyproterone acetate 100 mgs once daily, to suppress the flare in testosterone that can occur with initiation of GnRH analogues.
This is not required after subsequent injections.
TESTS:
* weeks after commencement of the above additional therapy, blood should be drawn for oestradiol, testosterone, prolactin, SHBG and Liver Function..